Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 1
ORB-021 In Patients With Advanced Solid Tumors
The goal of this clinical research study is to determine if an investigational new drug, named ORB-021, developed by Orionis Biosciences is safe and can be tol…
Advanced Solid Tumors Cancer
Orionis Biosciences IncNCT06607939
Phase 1
A Phase 1, Open-label, Multicenter Clinical Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Anti-Cancer Activity of PQ203 in Patients With Advanced Solid Tumor Malignancies
The primary purposes of this study are to determine the safety and tolerability of PQ203 in patients with advanced solid tumors including triple negative breas…
Triple Negative Breast Cancer (TNBC)Advanced Solid Tumors Cancer
ProteinQure Inc.NCT07190469
Phase 1
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of NDI-219216 in Patients With Advanced Solid Tumors With/Without Microsatellite Instability and/or Deficient Mismatch Repair
The goal of this clinical trial is to learn if NDI-219216 is safe for patients, and if NDI-219216 might be a possible treatment for advanced solid tumors in th…
Advanced Solid Tumors CancerMSI-H Cancer
Nimbus Wadjet, Inc.NCT06898450
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain …
CancerImmunotherapyAdvanced Solid Tumors Cancer+12 more
ElephasNCT07327489